Krtap9-5, a keratin-associated protein in mice, plays a pivotal role in cellular processes associated with identical protein binding activity. This suggests its involvement in molecular interactions crucial for maintaining cellular structure and function. The gene's orthology to human genes, such as KRTAP9-1, underscores its evolutionary conservation and potential functional significance across species. Krtap9-5 is predicted to be located in the cytosol, indicating its participation in intracellular events. While the precise function of Krtap9-5 remains to be fully elucidated, its involvement in identical protein binding points towards its contribution to molecular networks essential for various cellular functions.
The inhibition of Krtap9-5 involves a strategic approach targeting specific cellular pathways associated with its activity. Inhibitors such as mTOR inhibitor Rapamycin disrupt cellular processes downstream of mTOR, potentially impacting Krtap9-5 function. HDAC inhibitor Trichostatin A influences histone modifications, indirectly regulating Krtap9-5 and modulating cellular processes. Various inhibitors targeting TGF-β receptor, PI3K, JNK, p38 MAPK, EGFR, MEK, Wnt/β-catenin, and Rac1 pathways provide a comprehensive view of the intricate signaling networks connected to Krtap9-5. These inhibitors act at different points in these pathways, suggesting a nuanced regulation of Krtap9-5 function. Overall, the inhibition of Krtap9-5 reflects a complex interplay of diverse signaling cascades, contributing to our understanding of the molecular mechanisms governing this keratin-associated protein's role in cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $62.00 $155.00 $320.00 | 233 | |
mTOR inhibitor disrupting cellular processes, potentially impacting Krtap9-5 function. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
HDAC inhibitor affecting histone modifications, providing indirect regulation of Krtap9-5. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
TGF-β receptor inhibitor influencing cellular pathways associated with Krtap9-5. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $121.00 $392.00 | 148 | |
PI3K inhibitor disrupting PI3K/AKT pathway, potentially modulating Krtap9-5 activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
JNK inhibitor impacting JNK pathway, influencing cellular processes related to Krtap9-5. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $88.00 $342.00 | 284 | |
p38 MAPK inhibitor affecting p38 MAPK pathway, potentially altering Krtap9-5 function. | ||||||
Erlotinib, Free Base | 183321-74-6 | sc-396113 sc-396113A sc-396113B sc-396113C sc-396113D | 500 mg 1 g 5 g 10 g 100 g | $85.00 $132.00 $287.00 $495.00 $3752.00 | 42 | |
EGFR inhibitor potentially influencing downstream signaling pathways connected to Krtap9-5. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $63.00 $241.00 | 136 | |
MEK inhibitor disrupting the MAPK pathway, potentially impacting Krtap9-5 activity. | ||||||
Niclosamide | 50-65-7 | sc-250564 sc-250564A sc-250564B sc-250564C sc-250564D sc-250564E | 100 mg 1 g 10 g 100 g 1 kg 5 kg | $37.00 $77.00 $184.00 $510.00 $1224.00 $5814.00 | 8 | |
Inhibits Wnt/β-catenin signaling, potentially affecting pathways connected to Krtap9-5. | ||||||
GW788388 | 452342-67-5 | sc-363544 sc-363544A | 5 mg 25 mg | $95.00 $384.00 | ||
TGF-β receptor kinase inhibitor, potentially influencing cellular processes associated with Krtap9-5. | ||||||